Table 2.
Mechanisms of Activin Social Network Function in Breast
| Activin Network Member | Model | Outcome | Investigator |
|---|---|---|---|
| Activin A | Activin A treatment of human mammary epithelial organoids | Inhibits HGF-induced tubule formation | Liu et al. (24), 1996 |
| Activin A | Activin A treatment of luminal breast cancer cell lines | Induces G1 cell cycle arrest dependent on activin-induced SMAD and p38/MAPK signaling | Burdette et al. (63), 2005 |
| Activin A | Activin A treatment of luminal breast cancer cell lines | Inhibits estrogen-induced transcription activity and estrogen inhibits activin B expression and SMAD signaling | Burdette and Woodruff (65), 2007 |
| Activin A | Genotoxic stress of mammary epithelia and stromal fibroblasts | Increased activin A leading to COX-2 and cytokine induction, promotes protumorigenic cancer-associated fibroblasts and desmoplasia | Fordyce et al. (66), 2012 |
| Activin A | Activin A treatment of mammary epithelial cells | Represses CD36 expression in adjacent fibroblasts contributing to dense breasts and increased breast cancer risk | DeFilippis et al. (67), 2012; DeFilippis et al. (68), 2014 |
| Activin/Nodal | Activin/nodal inhibition of Luminal and basal breast cancer cell lines | Interconversion of differentiated breast cancer cells into cancer stem cells | Meyer et al. (69), 2009 |
| Activin A | Activin A overexpression in luminal or knockdown in basal breast cancer cell lines | Activin A promotes and is necessary to maintain the CD44+/CD24− cancer stem cell population | Bashir et al. (22), 2015 |
| Activin A | Overexpression or treatment with activin A of breast cancer cell lines | Activin A overexpression or treatment promotes migration, invasion and select EMT characteristics in breast cancer cell lines | Bashir et al. (22), 2015; Seachrist et al. (28), 2017; Neel and Lebrun (70), 2013 |
Abbreviation: HGF, hepatocyte growth factor.